Sumitomo Chemical India Ltd Q2 FY27 results are out (Jul–Sep 2026) →Revenue ₹891 Cr −2.5% YoYSee revenue, profit and what management said. You are viewing Q1 FY25.
SC

Sumitomo Chemical India Ltd

Q1 FY25Fertilizers & Agrochemicals

Sumitomo Chemical India Q1 FY25 earnings call: Revenue & Margins

Q1 FY25 investor presentation: what the company reported on revenue, margins and capex.

Revenue
₹832Cr
+25.3% QoQ
Net profit
₹128Cr
+17.4% QoQ
Margin
19%
−2 pp QoQ

Based on Sumitomo Chemical India Ltd's Q1 FY25 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.

Price₹450
Market cap₹23.0K Cr
P/E40.3

The short version

Q1FY25 Revenue from Operations: Rs. 838.9 Cr, up 16% YoY from Rs. 724.2 Cr in Q1FY24 (Page 11). Q1FY25 EBITDA: Rs. 161.1 Cr, up 100% YoY from Rs. 80.6 Cr in Q1FY24.

From Sumitomo Chemical India Ltd's Q1 FY25 earnings-call transcript · updated 24 Sept 2026.

Revenue & Sales Performance

  • Q1FY25 Revenue from Operations: Rs. 838.9 Cr, up 16% YoY from Rs. 724.2 Cr in Q1FY24 (Page 11).
  • Q1FY25 Gross Profit: Rs. 326.4 Cr, 38.9% margin, 780 bps improvement YoY (Page 11).
  • Q1FY25 EBITDA: Rs. 161.1 Cr, 19.2% margin, 807 bps improvement YoY (Page 11).
  • Q1FY25 Net Profit: Rs. 126.7 Cr, 15.1% margin, up 105% YoY (Page 11).

2 more points from Sumitomo Chemical India Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

Q1FY25 EBITDA: Rs. 161.1 Cr, up 100% YoY from Rs. 80.6 Cr in Q1FY24

Locked: what Sumitomo Chemical India Ltd said on margins

Also locked on this page: fundraising, order book

Free account, 30 seconds. No card needed.

Capital Expenditure Plans

  • The company plans to invest approximately 15% of consolidated EBITDA annually for upgrading manufacturing facilities and capacity expansion to meet strong domestic and global demand.
  • Emphasis on driving operational efficiencies while maintaining high safety standards and Responsible Care compliances during expansions.
  • Continued investment in R&D for seamless integration between SCIL and SCC units to improve production processes, yields, and efficiency is planned.
  • Multiple new products are in the pipeline, including global specialty proprietary products and combination/pre-mixture formulations for domestic and export markets, indicating capacity expansion aligned with these launches.

Top-ranked in Fertilizers & Agrochemicals

Ranked on what management guided this quarter

Guidance-ranked
1Anya Polytech &
Rev 2Mar 1
Rev 2Mar 2
3
Rev 2Mar 3
4
Rev 2Mar 3
5
Rev 2Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

Borrowings details from the Consolidated Balance Sheet (Page 34) show minimal current borrowings of Rs.…

Locked: what Sumitomo Chemical India Ltd said on fundraising

Also locked on this page: margins, order book

Free account, 30 seconds. No card needed.

Order Book & Pipeline

See what Sumitomo Chemical India Ltd said on order book & pipeline — free account, 30 seconds.

Sumitomo Chemical India Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Sumitomo Chemical India Ltd Q1 FY25 results — key figures

Sumitomo Chemical India Ltd Q1 FY25 reported results vs year-ago quarter, ₹ crore
₹ CrQ1 FY25Q4 FY24QoQ
Revenue832664+25.3%
Operating profit (EBITDA)162139+16.5%
Operating margin19%21%-2 pp
Profit before tax173149+16.1%
Net profit (PAT)128109+17.4%
EPS (₹)2.572.19+17.4%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹891 Cr, net profit ₹156 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Fertilizers & Agrochemicals this season

  • Madhya Bharat Agro Products (Q1 FY25)

    982 crore . Key concall takeaways from Madhya Bharat Agro Products Ltd's Q1 FY25 earnings call — and how it ranks against sector peers.

  • Paradeep Phosphates (Q1 FY25)

    23,774 million, down 22.2% YoY (Page 11). Key concall takeaways from Paradeep Phosphates Ltd's Q1 FY25 earnings call — and how it ranks against sector peers.

  • Heranba Inds (Q1 FY25)

    Q1FY25: ₹304.35 crore . Key concall takeaways from Heranba Industries Ltd's Q1 FY25 earnings call — and how it ranks against sector peers.

  • Dharmaj Crop (Q1 FY25)

    Revenue from Operations for Q1FY25: ₹2,553 million, a 62% year-on-year (YoY) increase from ₹1,575 million in Q1FY24. Key concall takeaways from Dharmaj Crop…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Sumitomo Chemical India Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Sumitomo Chemical India Ltd Q1 FY25 results?

Q1FY25 Revenue from Operations: Rs. 838.9 Cr, up 16% YoY from Rs. 724.2 Cr in Q1FY24 (Page 11). Q1FY25 EBITDA: Rs. 161.1 Cr, up 100% YoY from Rs. 80.6 Cr in Q1FY24.

What is Sumitomo Chemical India Ltd share price analysis?

Sumitomo Chemical India Ltd currently shows a neutral. The stock trades at a P/E of 40.3 with a market cap of ₹23,003 Cr. Investors should review the full earnings analysis for detailed insights.

Is Sumitomo Chemical India Ltd planning capital expenditure?

The company plans to invest approximately 15% of consolidated EBITDA annually for upgrading manufacturing facilities and capacity expansion to meet strong domestic and global demand.

Keep Sumitomo Chemical India Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.